Your browser doesn't support javascript.
loading
Contrast Media-Enhanced Breast Computed Tomography With a Photon-Counting Detector: Initial Experiences on In Vivo Image Quality and Correlation to Histology.
Berger, Nicole; Marcon, Magda; Wieler, Jann; Vorburger, Denise; Dedes, Konstantin J; Frauenfelder, Thomas; Varga, Zsuzsanna; Boss, Andreas.
Affiliation
  • Berger N; From the Institute of Diagnostic and Interventional Radiology.
  • Marcon M; From the Institute of Diagnostic and Interventional Radiology.
  • Wieler J; From the Institute of Diagnostic and Interventional Radiology.
  • Vorburger D; Breast Center.
  • Dedes KJ; Breast Center.
  • Frauenfelder T; From the Institute of Diagnostic and Interventional Radiology.
  • Varga Z; Institute of Pathology and Molecular Pathology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Boss A; From the Institute of Diagnostic and Interventional Radiology.
Invest Radiol ; 57(10): 704-709, 2022 10 01.
Article in En | MEDLINE | ID: mdl-35220384
ABSTRACT

OBJECTIVES:

The aim of this study was to investigate the feasibility, the image quality, and the correlation with histology of dedicated spiral breast computed tomography (B-CT) equipped with a photon-counting detector in patients with suspicious breast lesions after application of iodinated contrast media. MATERIALS AND

METHODS:

The local ethics committee approved this prospective study. Twelve women with suspicious breast lesions found in mammography or B-CT underwent contrast-enhanced spiral B-CT and supplementary ultrasound. For all lesions, biopsy-proven diagnosis and histological workup after surgical resection were obtained including the size of cancer/ductal carcinoma in situ, which were correlated to sizes measured in B-CT. Signal-to-noise ratio and contrast-to-noise ratio were evaluated for tumor, glandular tissue, and fatty tissue.

RESULTS:

Of the 12 patients, 15 suspicious lesions were found, 14 were malignant, and 1 benign lesion corresponded to a chronic inflammation. All lesions showed strong contrast media uptake with a signal-to-noise ratio of 119.7 ± 52.5 with a contrast-to-noise ratio between glandular tissue and breast cancer lesion of 12.6 ± 5.9. The correlation of the size of invasive tumors measured in B-CT compared with histological size was significant and strong R = 0.77 ( P < 0.05), whereas the correlation with the size of the peritumoral ductal carcinoma in situ was not significant R = 0.80 ( P = 0.11).

CONCLUSIONS:

Contrast-enhanced B-CT shows high contrast between breast cancer and surrounding glandular tissue; therefore, it is a promising technique for cancer detection and staging depicting both soft tissue lesions and microcalcifications, which might be a substantial advantage over breast MRI.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Carcinoma, Intraductal, Noninfiltrating / Carcinoma, Ductal Type of study: Observational_studies Aspects: Ethics Limits: Female / Humans Language: En Journal: Invest Radiol Year: 2022 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Carcinoma, Intraductal, Noninfiltrating / Carcinoma, Ductal Type of study: Observational_studies Aspects: Ethics Limits: Female / Humans Language: En Journal: Invest Radiol Year: 2022 Document type: Article